Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
542
datasets available to search
ShareScore release 0.9.0
Dataset results
542 results for “HIV prevention”
Data from: How can we get close to zero?: the potential contribution of biomedical prevention and the investment framework towards an effective response to HIV
Open the record for dataset details and reuse information.
Data from: Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women
Open the record for dataset details and reuse information.
Data from: National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia
<p><strong>Background:</strong> Namibia introduced the prevention of mother to child HIV transmission (MTCT) program in 2002 and lifelong antiretroviral therapy (ART) for pregnant women (option B-plus) in 2013. We sought to quantify MTCT measured at 4-12 weeks post-delivery.</p> <p><strong>Methods:</strong> During Aug 2014-Feb 2015, we recruited a nationally representative sample of 1040 pairs of mother and infant aged 4-12 weeks at routine immunizations in 60 public health clinics using two stage sampling approach. Of these, 864 HIV exposed infants had DNA-PCR HIV test results available. We defined an HIV exposed infant if born to an HIV-positive mother with documented status or diagnosed at enrollment using rapid HIV tests. Dried Blood Spots samples from HIV exposed infants were tested for HIV. Interview data and laboratory results were collected on smartphones and uploaded to a central database. We measured MTCT prevalence at 4-12 weeks post-delivery and evaluated associations between infant HIV infection and maternal and infant characteristics including maternal treatment and infant prophylaxis. All statistical analyses accounted for the survey design.</p> <p><strong>Results:</strong> Based on the 864 HIV exposed infants with test results available, nationally weighted early MTCT measured at 4-12 weeks post-delivery was 1.74% (95% confidence interval (CI): 1.00%-3.01%). Overall, 62% of mothers started ART pre-conception, 33.6% during pregnancy, 1.2% post-delivery and 3.2% never received ART. Mothers who started ART before pregnancy and during pregnancy had low MTCT prevalence, 0.78% (95% CI: 0.31%-1.96%) and 0.98% (95% CI: 0.33%-2.91%), respectively. MTCT rose to 4.13% (95% CI: 0.54%-25.68%) when the mother started ART after delivery and to 11.62% (95% CI: 4.07%-28.96%) when she never received ART. The lowest MTCT of 0.76% (95% CI: 0.36% - 1.61%) was achieved when mother received ART and ARV prophylaxis within 72hrs for infant and highest 22.32% (95%CI: 2.78% -74.25%) when neither mother nor infant received ARVs. After adjusting for mother's age, maternal ART (Prevalence Ratio (PR)=0.10, 95% CI: 0.03 – 0.29) and infant ARV prophylaxis (PR=0.32, 95% CI: 0.10 – 0.998) remained strong predictors of HIV transmission.</p> <p><strong>Conclusion:</strong> As of 2015, Namibia achieved MTCT of 1.74%, measured at 4-12 weeks post-delivery. Women already on ART pre-conception had the lowest prevalence of MTCT emphasizing the importance of early HIV diagnosis and treatment initiation before pregnancy. Studies are needed to measure MTCT and maternal HIV seroconversion during breastfeeding.</p>
Figure 1 in Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Figure 1. Flow of study participants in the present trial (VAX004). rgp, recombinant glycoprotein.
A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
ClinicalTrials.gov study NCT00002058. IPD Sharing: Not stated. Countries: 1. Publications: 2.
HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention
ClinicalTrials.gov study NCT03465852. IPD Sharing: YES. Countries: 1. Publications: 0.
Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda
ClinicalTrials.gov study NCT02596282. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma
ClinicalTrials.gov study NCT07103525. IPD Sharing: YES. Countries: 1. Publications: 0.
Pilot Intervention to Empower HIV Clients as Prevention Advocates in Uganda
ClinicalTrials.gov study NCT03435497. IPD Sharing: NO. Countries: 1. Publications: 0.
A Network & Dyad HIV Prevention Intervention for IDU's - 1
ClinicalTrials.gov study NCT00218335. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)
ClinicalTrials.gov study NCT06799702. IPD Sharing: NO. Countries: 1. Publications: 0.
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
ClinicalTrials.gov study NCT07073924. IPD Sharing: YES. Countries: 1. Publications: 0.
Mobile HIV Prevention App for Black Women
ClinicalTrials.gov study NCT05080972. IPD Sharing: YES. Countries: 1. Publications: 0.
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
ClinicalTrials.gov study NCT00667563. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
ClinicalTrials.gov study NCT00639938. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Social Media HIV Prevention Intervention for High Risk Rural Women
ClinicalTrials.gov study NCT03456453. IPD Sharing: NO. Countries: 1. Publications: 0.
Packaging PrEP to Prevent HIV Among WWID
ClinicalTrials.gov study NCT03304912. IPD Sharing: NO. Countries: 1. Publications: 0.
Podcasting HIV Prevention Within African American Communities
ClinicalTrials.gov study NCT05365958. IPD Sharing: NO. Countries: 1. Publications: 0.
Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and Care
ClinicalTrials.gov study NCT05925374. IPD Sharing: NO. Countries: 1. Publications: 0.
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)
ClinicalTrials.gov study NCT04417946. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.